Previous 10 | Next 10 |
2024-05-14 11:18:02 ET Illumina, Inc. (ILMN) RBC Capital Markets Global Healthcare Call May 14, 2024 08:30 ET Company Participants Ankur Dhingra - Chief Financial Officer Salli Schwartz - Investor Relations Conference Call Participants Conor McNamara - RB...
2024-05-10 06:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genomics is the future of medicine. With it, companies are racing to shed light on human health and disease. Over the last two decades, related studies have allowed us to create genetic risk sc...
2024-05-07 07:03:33 ET More on Illumina Illumina: Expect A Slow Rebound Illumina, Inc. (ILMN) Q1 2024 Earnings Call Transcript Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides Illumina Non-GAAP EPS of $0.09 misses by $0.01, rev...
2024-05-06 23:21:03 ET Summary Illumina is a biotechnology company that provides sequencing and array solutions for genomics and molecular diagnostics. Transition into newer NovaSeq X presents attractive growth acceleration opportunity, but it will take time. Illumina's revenu...
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL PR Newswire GRAIL to host Capital Markets Day on May 13 , 2024 SAN DIEGO , May 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it h...
2024-05-03 15:30:03 ET Stephens analyst issues NEUTRAL recommendation for ILMN on May 3, 2024 01:00PM ET. The previous analyst recommendation was Neutral. ILMN was trading at $119.71 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...
2024-05-02 20:39:08 ET Illumina, Inc. (ILMN) Q1 2024 Earnings Call Transcript May 2, 2024 05:00 PM ET Company Participants Salli Schwartz - Vice President, Investor Relations Jacob Thaysen - Chief Executive Officer Ankur Dhingra - Chief Financial Officer Joyd...
2024-05-02 16:07:48 ET More on Illumina Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition Illumina, Inc. (ILMN) Q4 2023 Earnings Call Transcript Illumin...
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 PR Newswire Core Illumina revenue of $1.06 billion for Q1 2024, down 2% from Q1 2023 (down 2% on a constant currency basis) Core Illumina GAAP operating margin of 11.0% and non-GAAP operating marg...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 12:15:03 ET Stephens analyst issues HOLD recommendation for ILMN on July 1, 2024 10:00AM ET. The previous analyst recommendation was Hold. ILMN was trading at $106.67 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current anal...